Stem Cell Therapy For Parkinson’s Disease Gets Approval For Human Testing – Tech Times
Tech Times |
Stem Cell Therapy For Parkinson’s Disease Gets Approval For Human Testing
Tech Times Biotechnology company International Stem Cell Corp. (ISCO) is authorized by the Australian government to conduct a clinical trial in patients with moderate to severe Parkinson’s disease. The company’s subsidiary, Cyto Therapeutics, received regulatory … Parkinson’s stem cell therapy OK’d for testingThe San Diego Union-Tribune stem cell therapy trial for Parkinson’s disease to be held in AustraliaABC Online Australian stem cell bid to cure Parkinson’s diseaseThe Australian (blog) 9news.com.au –Dove Medical Press –International Business Times AU all 16 news articles » |
|
‘Stem–cell therapy in research phase’
Times of India NASHIK : While there are reports that stem–cell therapy holds promise for Type 2 diabetes patients, leading medical practitioners in the city said on Sunday that stem–cell therapy for Type 1 diabetes was currently on experimental and only in research … |
Phys.Org |
Cell memory loss enables the production of stem cells
Phys.Org Adult cells, such as skin or blood cells, have a cellular “memory,” or record of how the cell changes as it develops from an uncommitted embryonic cell into a specialized adult cell. Now, Harvard Stem Cell Institute researchers at Massachusetts General … |
EurekAlert (press release) |
Cell memory loss enables the production of stem cells
EurekAlert (press release) Adult cells, such as skin or blood cells, have a cellular “memory,” or record of how the cell changes as it develops from an uncommitted embryonic cell into a specialized adult cell. Now, Harvard Stem Cell Institute researchers at Massachusetts General … |
LifeNews.com |
Video: Stem Cell Scientist Asks, “What if My Neighbor’s Kid Was Genetically …
LifeNews.com Paul Knoepfler is a stem cell scientist who is by no means a conservative, but he clearly gets what is at stake when we talk about germ-line genetic enhancements. He gave this TED Talk in Vienna that is fantastic. I will let him walk you through the … |
Nature.com |
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem …
Nature.com Thus, a ‘senolytic’ pharmacological agent that can selectively kill SCs holds promise for rejuvenating tissue stem cells and extending health span. To test this idea, we screened a collection of compounds and identified ABT263 (a specific inhibitor of … |